← Open Payments lookup

GREGORY FOX: Open Payments

NPI 1427230713 · GAUTIER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,762 in 169 payments from 14 companies in 2025. Trend: 2023 $2,900 · 2024 $3,117 · 2025 $2,762

Food & beverage: $2,583Education: $179
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$513
Teva Pharmaceuticals USA, Inc.23$445
ABBVIE INC.40$382
Lundbeck LLC19$325
Supernus Pharmaceuticals, Inc.17$271
Axsome Therapeutics, Inc.17$222
Janssen Pharmaceuticals, Inc6$111
Neurocrine BioSciences, Inc.4$104
Otsuka America Pharmaceutical, Inc.4$89
E.R. Squibb & Sons, L.L.C.3$89

Products named: CAPLYTA, VRAYLAR, Qelbree, REXULTI, Auvelity, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across MS — which companies pay providers there.